Authors have suggested that this effect is associated with the upregulation of high-density lipoprotein-associated antioxidant paraoxonase (PON) after atorvastatin treatment in CAD patients resulting in lipid peroxidation inhibition followed by the reduction of oxidative DNA damage [68]. The gene discussed is PON1; the disease is coronary artery disorder.